Lve Cheng

机构：Dalian Medical University, Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University

发表论文 5 篇 · 总被引 27 次 · h-index 2

代表论文

• Targeting FDFT1 Reduces Cholesterol and Bile Acid Production and Delays Hepatocellular Carcinoma Progression Through the HNF4A/ALDOB/AKT1 Axis (2025 · Advanced Science · 被引 22)
• Risk Factors for Systemic Inflammatory Response Syndrome After Percutaneous Transhepatic Cholangioscopic Lithotripsy (2024 · Journal of Inflammation Research · 被引 4)
• Integrating bioinformatics and experimental validation to reveal a novel VRK score as a prognostic and therapeutic biomarker in hepatocellular carcinoma (2025 · Frontiers in Immunology · 被引 1)
• Development and validation of a prediction model for cholangitis after percutaneous transhepatic cholangioscopic lithotripsy (2025 · Clinical and Experimental Medicine)
• Nomogram for Predicting Sepsis After Percutaneous Transhepatic Cholangioscopic Lithotripsy (2025 · Journal of Inflammation Research)